Zimbabwe has turned down a major American health deal valued at $367m (£272m) spanning five years over the United States' request for sensitive information.
This rejection was revealed following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
A government spokesman later explained that the US was demanding access to biological samples for research and profit but was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued negotiations to reach a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
This rejection follows a similar situation in Kenya, where a high court suspended a related health funding agreement following concerns were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
As per statements, 16 nations in Africa have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"In essence, our nation would provide the basic resources for scientific discovery without any assurance that the resulting innovations would be accessible to our population if a new disease outbreak emerge."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining systems previously established via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This system is designed to ensure that when a country provides its information, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing discussions with our American counterparts on how subsequent collaboration might be designed in a way that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks should continue considering a large portion of the country's Aids initiatives were funded by international support.
"Where technical issues arise, including those relating to data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it said.
This impasse highlights the ongoing challenges between accepting vital international aid and protecting local interests in an ever more data-driven world.